Stryker’s Foot & Ankle unit announced U.S. availability of SonicAnchor™, reportedly the only implant in the U.S. that employs ultrasonic energy to liquefy and flow into cancellous bone, for suture or tissue fixation in a variety of open procedures.
Study results suggest that use of K2M’s MESA Rail™ Deformity Spinal System may yield significantly better major curve correction than circular rod constructs in the treatment of Adolescent Idiopathic Scoliosis.
Titan Spine closed a substantial round of financing. Proceeds will support U.S. sales expansion and surgeon adoption of Endoskeleton® titanium interbody fusion implants and launch of next-generation nanoLOCK™ surface technology.
Spineart received CE Mark Approval for its JULIET®Ti lumbar interbody systems featuring TI-LIFE, a micro-porous scaffold designed to mimic trabecular bone.
The first commercial U.S. patient has received the Cartiva Synthetic Cartilage Implant following its FDA Premarket Approval for the treatment of great toe arthritis.